ASTARABINE Trademark
Serial Number: 97403419
ASTARABINE is a trademark filed by
BioSight Ltd.
on May 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jacqueline Zion PEARL COHEN ZEDEK LATZER BARATZ LLP
7 TIMES SQUARE, 19TH FL
NEW YORK, NY 10036
United States
Trademark Details
Filing Date
May 10, 2022
Registration Date
Not Registered
Published for Opposition
April 4, 2023
Goods & Services
Pharmaceutical preparations containing arabinofuranosyl derivatives for the treatment of cancer
Filing History
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 29, 2024 EX2G
SOU EXTENSION 2 FILED
May 29, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 29, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 2, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 2, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 2, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 2, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2022 NWOS
NEW APPLICATION ENTERED
May 13, 2022 NWAP
